Study to improve the identification of patients who are candidates for second-line therapies (SLT) in Parkinson's disease. DELIST-PD STUDY
INDEPENDENT POST AUTHORIZATION STUDY
Clinical trial information
- Promoter: FOUNDATION OF THE SPANISH SOCIETY OF NEUROLOGY
- Execution start: 27/10/2020
- End of execution: 30/06/2021
- PI: FRANCISCO ESCAMILLA SEVILLA